[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Venlafaxine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Venlafaxine.]
[J01GA01, streptomycin, Venlafaxine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Venlafaxine.]
[A02BX02, sucralfate, Venlafaxine may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Venlafaxine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Venlafaxine.]
[S01AB02, sulfisoxazole, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfisoxazole.]
[M01AB02, sulindac, Venlafaxine may increase the antiplatelet activities of Sulindac.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sulpiride.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sulthiame.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glymidine.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Venlafaxine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Venlafaxine.]
[L01CB02, teniposide, Venlafaxine may increase the excretion rate of Teniposide which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC03, terbutaline, Venlafaxine may increase the tachycardic activities of Terbutaline.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Venlafaxine.]
[G03BA03, testosterone, Venlafaxine may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Venlafaxine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tetracaine.]
[S03AA02, tetracycline, Venlafaxine may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05AE05, lurasidone, The risk or severity of serotonin syndrome can be increased when Lurasidone is combined with Venlafaxine.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[N04BC07, apomorphine, The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Venlafaxine.]
[L04AX02, thalidomide, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Venlafaxine.]
[P02CA02, thiabendazole, Venlafaxine may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiethylperazine.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of serotonin syndrome can be increased when Thioridazine is combined with Venlafaxine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Venlafaxine.]
[G04BE06, moxisylyte, Venlafaxine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tiapride.]
[B01AC05, ticlopidine, The risk or severity of bleeding can be increased when Ticlopidine is combined with Venlafaxine.]
[N02AX01, tilidine, The risk or severity of serotonin syndrome can be increased when Tilidine is combined with Venlafaxine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Venlafaxine.]
[P01AB02, tinidazole, Venlafaxine may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Venlafaxine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Tolbutamide.]
[M02AA21, tolmetin, Venlafaxine may increase the antiplatelet activities of Tolmetin.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Venlafaxine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Venlafaxine.]
[N06AX05, trazodone, Venlafaxine may increase the serotonergic activities of Trazodone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triazolam.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB12, mepenzolate, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[A16AX12, trientine, Venlafaxine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trifluoperazine.]
[S01AD02, trifluridine, Venlafaxine may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trifluperidol.]
[N05AA05, triflupromazine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trimethadione.]
[J01EA01, trimethoprim, Venlafaxine may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Venlafaxine.]
[R06AC04, tripelennamine, The metabolism of Venlafaxine can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triprolidine.]
[A03BB01, butylscopolamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Venlafaxine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Venlafaxine.]
[N06AX02, tryptophan, The risk or severity of serotonin syndrome can be increased when Tryptophan is combined with Venlafaxine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tubocurarine.]
[R03DX07, roflumilast, Venlafaxine may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Venlafaxine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Venlafaxine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Venlafaxine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Venlafaxine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Venlafaxine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Venlafaxine can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Venlafaxine.]
[S01AA28, vancomycin, Venlafaxine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ezogabine.]
[B01AF01, rivaroxaban, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Venlafaxine.]
[R03AC18, indacaterol, Venlafaxine may increase the tachycardic activities of Indacaterol.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Venlafaxine.]
[C08DA01, verapamil, The metabolism of Venlafaxine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Venlafaxine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Venlafaxine can be decreased when combined with Vinblastine.]
[L01CA02, vincristine, Venlafaxine may increase the excretion rate of Vincristine which could result in a lower serum level and potentially a reduction in efficacy.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Warfarin is combined with Venlafaxine.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, Venlafaxine may increase the excretion rate of Zidovudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Venlafaxine.]
[J05AE02, indinavir, The serum concentration of Indinavir can be decreased when it is combined with Venlafaxine.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Levetiracetam.]
[L01EC01, vemurafenib, Venlafaxine may increase the excretion rate of Vemurafenib which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M05BA05, tiludronic acid, Venlafaxine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Venlafaxine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Venlafaxine can be decreased when combined with Crizotinib.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Venlafaxine.]
[A02BC04, rabeprazole, Venlafaxine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Venlafaxine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Venlafaxine may increase the antiplatelet activities of Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Venlafaxine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Venlafaxine.]
[J01DH04, doripenem, Venlafaxine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Venlafaxine.]
[J02AC03, voriconazole, The risk or severity of adverse effects can be increased when Voriconazole is combined with Venlafaxine.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atracurium.]
[S01FA01, atropine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[M01CB03, auranofin, Venlafaxine may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Venlafaxine may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Venlafaxine may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Venlafaxine may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Venlafaxine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Venlafaxine may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Venlafaxine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[A08AA11, lorcaserin, The risk or severity of serotonin syndrome can be increased when Lorcaserin is combined with Venlafaxine.]
[G04BD12, mirabegron, The serum concentration of Venlafaxine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Venlafaxine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Venlafaxine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Venlafaxine can be decreased when it is combined with Enzalutamide.]
[L04AA31, teriflunomide, Venlafaxine may increase the excretion rate of Teriflunomide which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Venlafaxine.]
[C01CA18, octopamine, Venlafaxine may increase the tachycardic activities of Octopamine.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Barbital.]
[D02BA02, octinoxate, Venlafaxine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Venlafaxine can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[N04BD02, rasagiline, The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Venlafaxine.]
[A03FA09, mosapride, The risk or severity of serotonin syndrome can be increased when Mosapride is combined with Venlafaxine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Venlafaxine.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[N02CC03, zolmitriptan, The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Zolmitriptan.]
[R06AC06, thonzylamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Venlafaxine.]
[V09IX04, fluorodeoxyglucose F18, Venlafaxine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Diethyl ether.]
[H01CB05, pasireotide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Venlafaxine.]
[V08CA11, gadofosveset, Venlafaxine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Venlafaxine.]
[B01AF02, apixaban, The risk or severity of bleeding can be increased when Apixaban is combined with Venlafaxine.]
[A16AX08, teduglutide, Venlafaxine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Venlafaxine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Venlafaxine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Venlafaxine can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Benperidol.]
[A10BK02, canagliflozin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Canagliflozin.]
[A06AX06, tegaserod, The risk or severity of serotonin syndrome can be increased when Tegaserod is combined with Venlafaxine.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Venlafaxine.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pramlintide.]
[L03AA12, ancestim, Venlafaxine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of bleeding can be increased when Celecoxib is combined with Venlafaxine.]
[N02CC02, naratriptan, The risk or severity of serotonin syndrome can be increased when Naratriptan is combined with Venlafaxine.]
[L04AA18, everolimus, The metabolism of Venlafaxine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Venlafaxine.]
[L01EC02, dabrafenib, The serum concentration of Venlafaxine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01EE01, trametinib, Venlafaxine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Venlafaxine.]
[V09AX05, florbetapir F-18, Venlafaxine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Venlafaxine may increase the excretion rate of Afatinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Venlafaxine.]
[J05AJ03, dolutegravir, Venlafaxine may increase the excretion rate of Dolutegravir which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Venlafaxine.]
[C02KX05, riociguat, Venlafaxine may increase the excretion rate of Riociguat which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Lixisenatide.]
[C02KX04, macitentan, Venlafaxine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Venlafaxine.]
[N06AX26, vortioxetine, The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Venlafaxine.]
[G03AC08, etonogestrel, Venlafaxine may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Venlafaxine can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Venlafaxine may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Venlafaxine.]
[C01CA27, droxidopa, Venlafaxine may increase the tachycardic activities of Droxidopa.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Venlafaxine.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Venlafaxine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Venlafaxine can be increased when combined with Apremilast.]
[L02BG02, formestane, Venlafaxine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Venlafaxine.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Venlafaxine.]
[V03AB34, fomepizole, Venlafaxine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Venlafaxine may increase the tachycardic activities of Bethanidine.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Venlafaxine can be increased when combined with Siltuximab.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Venlafaxine.]
[A03BA03, hyoscyamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Acenocoumarol is combined with Venlafaxine.]
[L01EM01, idelalisib, Venlafaxine may increase the excretion rate of Idelalisib which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alfaxalone.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Empagliflozin.]
[R03AC19, olodaterol, Venlafaxine may increase the tachycardic activities of Olodaterol.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[D11AA01, glycopyrronium, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05CM19, suvorexant, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Venlafaxine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Venlafaxine can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Acepromazine.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Dulaglutide.]
[N04AA02, biperiden, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Venlafaxine.]
[S03AA06, gentamicin, Venlafaxine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Venlafaxine.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Venlafaxine.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Venlafaxine.]
[N06AX11, mirtazapine, Venlafaxine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Venlafaxine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, Venlafaxine may increase the excretion rate of Palbociclib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EX08, lenvatinib, Venlafaxine may increase the excretion rate of Lenvatinib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XH03, panobinostat, The metabolism of Venlafaxine can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Venlafaxine.]
[L01DC01, bleomycin, Venlafaxine may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[A03AA09, difemerine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Venlafaxine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Venlafaxine.]
[A07DA06, eluxadoline, The risk or severity of serotonin syndrome can be increased when Eluxadoline is combined with Venlafaxine.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Venlafaxine.]
[N05AX16, brexpiprazole, The risk or severity of serotonin syndrome can be increased when Brexpiprazole is combined with Venlafaxine.]
[A04AD14, rolapitant, The metabolism of Venlafaxine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of serotonin syndrome can be increased when Flibanserin is combined with Venlafaxine.]
[N05AX15, cariprazine, The risk or severity of serotonin syndrome can be increased when Cariprazine is combined with Venlafaxine.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Acarbose.]
[M02AA25, aceclofenac, Venlafaxine may increase the antiplatelet activities of Aceclofenac.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Acetazolamide.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin degludec.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Acetophenazine.]
[A02BC03, lansoprazole, The metabolism of Venlafaxine can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Venlafaxine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Venlafaxine.]
[J02AC05, isavuconazole, The metabolism of Venlafaxine can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Venlafaxine may increase the excretion rate of Osimertinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Venlafaxine.]
[L01XG03, ixazomib, Venlafaxine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Acetohexamide.]
[M04AB05, lesinurad, Venlafaxine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Venlafaxine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Bromazepam.]
[N04BC01, bromocriptine, Venlafaxine may increase the tachycardic activities of Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Venlafaxine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alverine.]
[R06AB01, brompheniramine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.]
[N06AA19, amineptin, The risk or severity of serotonin syndrome can be increased when Amineptine is combined with Venlafaxine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Aniracetam.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Venlafaxine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Venlafaxine.]
[N07BC01, buprenorphine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Venlafaxine.]
[L01XX27, arsenic trioxide, Venlafaxine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Venlafaxine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N02AF01, butorphanol, The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Venlafaxine.]
[S01GX07, azelastine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Venlafaxine.]
[L01EF02, ribociclib, The metabolism of Venlafaxine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Venlafaxine may increase the antiplatelet activities of Balsalazide.]
[R03CC12, bambuterol, Venlafaxine may increase the tachycardic activities of Bambuterol.]
[A06AH05, naldemedine, Venlafaxine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Venlafaxine.]
[N02BF02, pregabalin, The therapeutic efficacy of Venlafaxine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Beclamide.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Benfluorex.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Venlafaxine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the serotonergic activities of Venlafaxine.]
[J05AF06, abacavir, Venlafaxine may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Venlafaxine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Venlafaxine.]
[L04AB02, infliximab, The metabolism of Venlafaxine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Venlafaxine can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, Venlafaxine may increase the excretion rate of Brigatinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BD03, safinamide, The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Venlafaxine.]
[J01MA23, delafloxacin, Venlafaxine may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Venlafaxine.]
[L01BC06, capecitabine, Venlafaxine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Venlafaxine.]
[L01EM02, copanlisib, Venlafaxine may increase the excretion rate of Copanlisib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EF03, abemaciclib, Venlafaxine may increase the excretion rate of Abemaciclib which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB07, bisoprolol, Venlafaxine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[R03AC17, bitolterol, Venlafaxine may increase the tachycardic activities of Bitolterol.]
[J05AG03, efavirenz, The metabolism of Venlafaxine can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Venlafaxine.]
[N04AA11, bornaprine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Brotizolam.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Venlafaxine may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Venlafaxine.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Venlafaxine.]
[N06AA15, butriptyline, The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Venlafaxine.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Semaglutide.]
[A10BK04, ertugliflozin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Ertugliflozin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vinylbital.]
[R06AX18, acrivastine, Venlafaxine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, The metabolism of Venlafaxine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Venlafaxine.]
[A03AA03, camylofine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Carbinoxamine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Venlafaxine.]
[N03AX24, cannabidiol, The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Venlafaxine.]
[L04AA37, baricitinib, Venlafaxine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Venlafaxine.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01GB14, plazomicin, Venlafaxine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Venlafaxine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Venlafaxine.]
[L01XX62, ivosidenib, The metabolism of Venlafaxine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Venlafaxine.]
[A16AX14, migalastat, Venlafaxine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Venlafaxine can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Venlafaxine may increase the excretion rate of Lusutrombopag which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EM04, duvelisib, Venlafaxine may increase the excretion rate of Duvelisib which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Venlafaxine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cetirizine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Carbromal.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Carbutamide.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Venlafaxine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, Venlafaxine may increase the antiplatelet activities of Lornoxicam.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01XK04, talazoparib, Venlafaxine may increase the excretion rate of Talazoparib which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Venlafaxine.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Venlafaxine.]
[L04AA39, emapalumab, The metabolism of Venlafaxine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01EX13, gilteritinib, The therapeutic efficacy of Venlafaxine can be decreased when used in combination with Gilteritinib.]
[L01XJ03, glasdegib, Venlafaxine may increase the excretion rate of Glasdegib which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Venlafaxine is combined with Amifampridine.]
[A06AX05, prucalopride, Venlafaxine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01BG07, cifenline, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Cibenzoline.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Venlafaxine.]
[B01AC23, cilostazol, The risk or severity of bleeding can be increased when Cilostazol is combined with Venlafaxine.]
[A03FA08, cinitapride, The risk or severity of serotonin syndrome can be increased when Cinitapride is combined with Venlafaxine.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Venlafaxine.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Esketamine.]
[J01FA09, clarithromycin, The metabolism of Venlafaxine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Venlafaxine.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Brexanolone.]
[N05BA09, clobazam, The metabolism of Venlafaxine can be decreased when combined with Clobazam.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cloxazolam.]
[C01EB09, ubidecarenone, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Ubidecarenone.]
[L04AB01, etanercept, The metabolism of Venlafaxine can be increased when combined with Etanercept.]
[L01EM03, alpelisib, Venlafaxine may increase the excretion rate of Alpelisib which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L02BB06, darolutamide, Venlafaxine may increase the excretion rate of Darolutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cyamemazine.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Venlafaxine.]
[L01EJ02, fedratinib, The metabolism of Venlafaxine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Venlafaxine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Venlafaxine.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Venlafaxine.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin pork.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Venlafaxine.]
[N03AX25, cenobamate, The serum concentration of Venlafaxine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Venlafaxine can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Venlafaxine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, Venlafaxine may increase the excretion rate of Ubrogepant which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dexbrompheniramine.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Venlafaxine.]
[S01XA12, dexpanthenol, Venlafaxine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02AX03, dezocine, The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Venlafaxine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lemborexant.]
[L01XX72, tazemetostat, Venlafaxine may increase the excretion rate of Tazemetostat which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Venlafaxine can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, Venlafaxine may increase the excretion rate of Rimegepant which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AE06, gatifloxacin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Venlafaxine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Venlafaxine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of serotonin syndrome can be increased when Frovatriptan is combined with Venlafaxine.]
[L04AA38, ozanimod, Venlafaxine may increase the excretion rate of Ozanimod which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dichloralphenazone.]
[L01EE04, selumetinib, Venlafaxine may increase the excretion rate of Selumetinib which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AA03, dichlorobenzyl alcohol, Venlafaxine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Venlafaxine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of serotonin syndrome can be increased when Dihydrocodeine is combined with Venlafaxine.]
[N02CC06, eletriptan, The risk or severity of serotonin syndrome can be increased when Eletriptan is combined with Venlafaxine.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Venlafaxine.]
[C01BD07, dronedarone, The metabolism of Venlafaxine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Valpromide.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chlordiazepoxide.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Venlafaxine.]
[A03AA08, dihexyverine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[C01CA14, dopexamine, Venlafaxine may increase the tachycardic activities of Dopexamine.]
[G04BD09, trospium, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, Venlafaxine may increase the antiplatelet activities of Droxicam.]
[L01EX19, ripretinib, Venlafaxine may increase the excretion rate of Ripretinib which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA05, mangafodipir, Venlafaxine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Venlafaxine.]
[M02AA27, dexketoprofen, Venlafaxine may increase the antiplatelet activities of Dexketoprofen.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dyclonine.]
[J05AX29, fostemsavir, Venlafaxine may increase the excretion rate of Fostemsavir which could result in a lower serum level and potentially a reduction in efficacy.]
[P01BB01, proguanil, The metabolism of Venlafaxine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Venlafaxine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Venlafaxine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Venlafaxine.]
[L01EX23, pralsetinib, Venlafaxine may increase the excretion rate of Pralsetinib which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The risk or severity of serotonin syndrome can be increased when Chlorpheniramine is combined with Venlafaxine.]
[N05AA01, chlorpromazine, The risk or severity of serotonin syndrome can be increased when Chlorpromazine is combined with Venlafaxine.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Chlorpropamide.]
[N05AF03, chlorprothixene, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Venlafaxine.]
[A11CC05, cholecalciferol, The metabolism of Venlafaxine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Etifoxine.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N02BA03, choline salicylate, Venlafaxine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ethyl loflazepate.]
[M01AB08, etodolac, Venlafaxine may increase the antiplatelet activities of Etodolac.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[B06AC06, berotralstat, The metabolism of Venlafaxine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Venlafaxine can be decreased when combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Venlafaxine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Venlafaxine can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, Venlafaxine may increase the excretion rate of Trilaciclib which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Felbamate.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C01CA19, fenoldopam, Venlafaxine may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[N06BA08, fenozolone, The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Fenozolone.]
[J01DD15, cefdinir, Venlafaxine may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[N02BG07, flupirtine, Venlafaxine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Venlafaxine.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin human.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Venlafaxine can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Venlafaxine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Gabapentin.]
[V08CA04, gadoteridol, Venlafaxine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Venlafaxine.]
[L01XX73, sotorasib, The serum concentration of Venlafaxine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Venlafaxine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Venlafaxine may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Citalopram is combined with Venlafaxine.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Venlafaxine.]
[V09AB03, ioflupane I-123, Venlafaxine may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.]
[V09AA01, technetium Tc 99m exametazime, Venlafaxine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Venlafaxine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Venlafaxine.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gliquidone.]
[R03CC13, clenbuterol, Venlafaxine may increase the tachycardic activities of Clenbuterol.]
[N06AX25, St. John's wort extract, The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Venlafaxine.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Venlafaxine.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Venlafaxine.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Levobupivacaine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Venlafaxine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Venlafaxine.]
[C01EB24, mavacamten, The serum concentration of Venlafaxine can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Tirzepatide.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Venlafaxine.]
[A04AA02, granisetron, The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Venlafaxine.]
[L01XX77, adagrasib, The serum concentration of Venlafaxine can be increased when it is combined with Adagrasib.]
[N05AH02, clozapine, The metabolism of Clozapine can be decreased when combined with Venlafaxine.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sotagliflozin.]
[J01GB12, arbekacin, Venlafaxine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Venlafaxine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Venlafaxine.]
[C02KB01, metyrosine, Venlafaxine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Venlafaxine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[R05DA04, codeine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Venlafaxine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Hexafluronium.]
[M04AC01, colchicine, Venlafaxine may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[A03AB10, hexocyclium, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[J01XB01, colistin, Venlafaxine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L04AA13, leflunomide, Venlafaxine may increase the excretion rate of Leflunomide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Venlafaxine.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Venlafaxine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Venlafaxine.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Venlafaxine.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Desloratadine.]
[J05AB14, valganciclovir, Venlafaxine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Venlafaxine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Venlafaxine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Venlafaxine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Venlafaxine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Venlafaxine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[H01AX01, pegvisomant, The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Venlafaxine.]
[A03AX10, isometheptene, Venlafaxine may increase the tachycardic activities of Isometheptene.]
[N02CC05, almotriptan, The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Venlafaxine.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J02AC02, itraconazole, The metabolism of Venlafaxine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Venlafaxine.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Venlafaxine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Venlafaxine can be decreased when combined with Posaconazole.]
[N03AX09, lamotrigine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[N07BC04, lofexidine, The therapeutic efficacy of Venlafaxine can be increased when used in combination with Lofexidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lormetazepam.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C09AA03, lisinopril, Venlafaxine may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Venlafaxine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Venlafaxine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Medifoxamine.]
[A08AA09, mefenorex, The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Mefenorex.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Venlafaxine.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Venlafaxine.]
[J01DH02, meropenem, Venlafaxine may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C01EB10, adenosine, The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Adenosine.]
[N04AA03, methixene, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, The risk or severity of serotonin syndrome can be increased when Methoxyphenamine is combined with Venlafaxine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cyclobarbital.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Miglitol.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N06AX07, minaprine, The risk or severity of serotonin syndrome can be increased when Minaprine is combined with Venlafaxine.]
[S01XA18, cyclosporine, The metabolism of Venlafaxine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Venlafaxine.]
[R06AX02, cyproheptadine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C10AA07, rosuvastatin, Venlafaxine may increase the excretion rate of Rosuvastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Venlafaxine can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, Venlafaxine may increase the tachycardic activities of Moxonidine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01AX04, dacarbazine, Venlafaxine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01DA01, dactinomycin, Venlafaxine may increase the excretion rate of Dactinomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[G03XA01, danazol, The metabolism of Venlafaxine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dantrolene.]
[L01DB02, daunorubicin, Venlafaxine may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Venlafaxine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[M01AX01, nabumetone, Venlafaxine may increase the antiplatelet activities of Nabumetone.]
[N07BB05, nalmefene, Venlafaxine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Venlafaxine.]
[S01GX04, nedocromil, Venlafaxine may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Venlafaxine can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Niaprazine.]
[C01DX16, nicorandil, Venlafaxine may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Venlafaxine may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tiagabine.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cisatracurium.]
[C01CA05, norfenefrine, Venlafaxine may increase the tachycardic activities of Norfenefrine.]
[R05DA06, normethadone, The risk or severity of serotonin syndrome can be increased when Normethadone is combined with Venlafaxine.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Fondaparinux is combined with Venlafaxine.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Venlafaxine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N06AA01, desipramine, The serum concentration of the active metabolites of Desipramine can be increased when Desipramine is used in combination with Venlafaxine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[V04CH02, indigo carmine, Venlafaxine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Venlafaxine may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[L01XA03, oxaliplatin, Venlafaxine may increase the excretion rate of Oxaliplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE12, oxaprozin, Venlafaxine may increase the antiplatelet activities of Oxaprozin.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Venlafaxine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxiracetam.]
[N04AA08, dexetimide, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Venlafaxine.]
[A03AA01, oxyphencyclimine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Venlafaxine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Venlafaxine.]
[N06BA02, dextroamphetamine, The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Venlafaxine.]
[R05DA09, dextromethorphan, The risk or severity of serotonin syndrome can be increased when Dextromethorphan is combined with Venlafaxine.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of serotonin syndrome can be increased when Dextromoramide is combined with Venlafaxine.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Paroxetine is combined with Venlafaxine.]
[B01AC04, clopidogrel, The risk or severity of bleeding can be increased when Clopidogrel is combined with Venlafaxine.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Diamorphine.]
[P03AC04, permethrin, Venlafaxine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of serotonin syndrome can be increased when Dibenzepin is combined with Venlafaxine.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Cinchocaine.]
[R05DA08, pholcodine, Venlafaxine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Venlafaxine may increase the antiplatelet activities of Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[A03AA07, dicyclomine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[J05AF02, didanosine, Venlafaxine may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[A10BG03, pioglitazone, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pioglitazone.]
[N05AD05, pipamperone, The risk or severity of serotonin syndrome can be increased when Pipamperone is combined with Venlafaxine.]
[A03AB14, pipenzolate, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Venlafaxine.]
[R03CC07, pirbuterol, Venlafaxine may increase the tachycardic activities of Pirbuterol.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The risk or severity of serotonin syndrome can be increased when Diethylpropion is combined with Venlafaxine.]
[C08CA03, isradipine, The metabolism of Venlafaxine can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, Venlafaxine may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[A03AB11, poldine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, Venlafaxine may increase the antiplatelet activities of Diflunisal.]
[C01AA05, digoxin, Venlafaxine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Venlafaxine may increase the excretion rate of Ezetimibe which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA01, dihydroergotamine, The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Venlafaxine.]
[N02AA03, hydromorphone, The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Venlafaxine.]
[L04AX04, lenalidomide, Venlafaxine may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Venlafaxine can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Venlafaxine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Venlafaxine may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Venlafaxine.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Dimenhydrinate.]
[V03AB09, dimercaprol, Venlafaxine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pridinol.]
[R06AB03, dimethindene, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, Venlafaxine may increase the tachycardic activities of Procaterol.]
[M02AX03, dimethyl sulfoxide, The metabolism of Venlafaxine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Progabide.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[R06AA02, diphenhydramine, The risk or severity of serotonin syndrome can be increased when Diphenhydramine is combined with Venlafaxine.]
[A07DA01, diphenoxylate, The risk or severity of serotonin syndrome can be increased when Diphenoxylate is combined with Venlafaxine.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Quazepam.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Venlafaxine.]
[N06BA11, dexmethylphenidate, The risk or severity of serotonin syndrome can be increased when Dexmethylphenidate is combined with Venlafaxine.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Venlafaxine.]
[N06AA23, quinupramine, The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Venlafaxine.]
[A03FA02, cisapride, The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Venlafaxine.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Venlafaxine.]
[R03CC14, reproterol, Venlafaxine may increase the tachycardic activities of Reproterol.]
[S01AX06, resorcinol, Venlafaxine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[S02AA12, rifamycin SV, The metabolism of Venlafaxine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Venlafaxine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Riluzole.]
[N05AX08, risperidone, The risk or severity of serotonin syndrome can be increased when Risperidone is combined with Venlafaxine.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ropivacaine.]
[L01EX01, sunitinib, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Venlafaxine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Venlafaxine.]
[G04BE08, tadalafil, Venlafaxine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Venlafaxine may increase the antiplatelet activities of Ketorolac.]
[C01EB18, ranolazine, The serum concentration of Venlafaxine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Venlafaxine may increase the antiplatelet activities of Salsalate.]
[R03AC12, salmeterol, Venlafaxine may increase the tachycardic activities of Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C01CA07, dobutamine, Venlafaxine may increase the tachycardic activities of Dobutamine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Venlafaxine.]
[C01CA04, dopamine, Venlafaxine may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Venlafaxine.]
[N06AA12, doxepin, The risk or severity of serotonin syndrome can be increased when Doxepin is combined with Venlafaxine.]
[L01DB01, doxorubicin, The metabolism of Venlafaxine can be decreased when combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Sertraline is combined with Venlafaxine.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Sibutramine is combined with Venlafaxine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Venlafaxine.]
[A12CA02, sodium sulfate, Venlafaxine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Venlafaxine may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of serotonin syndrome can be increased when Sumatriptan is combined with Venlafaxine.]
[G01AF05, econazole, The metabolism of Venlafaxine can be decreased when combined with Econazole.]
[V04CX07, edrophonium, Venlafaxine may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Venlafaxine.]
[L01AX03, temozolomide, Venlafaxine may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Venlafaxine may increase the antiplatelet activities of Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Venlafaxine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Venlafaxine.]
[S01GA02, tetrahydrozoline, Venlafaxine may increase the tachycardic activities of Tetryzoline.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiopropazate.]
[G04BD01, emepronium, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The risk or severity of serotonin syndrome can be increased when Tianeptine is combined with Venlafaxine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tofisopam.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N06AG03, toloxatone, The risk or severity of serotonin syndrome can be increased when Toloxatone is combined with Venlafaxine.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Venlafaxine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Venlafaxine.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Tramazoline.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triclofos.]
[A03AB08, tridihexethyl, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Venlafaxine.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Venlafaxine.]
[R03CC11, tulobuterol, Venlafaxine may increase the tachycardic activities of Tulobuterol.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Venlafaxine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Venlafaxine can be decreased when combined with Vinorelbine.]
[S01FB02, ephedrine, Venlafaxine may increase the tachycardic activities of Ephedrine.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Venlafaxine.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Venlafaxine.]
[N07XX04, sodium oxybate, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[S02BA08, fluocinolone acetonide, Venlafaxine may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[M01AG01, mefenamic acid, Venlafaxine may increase the antiplatelet activities of Mefenamic acid.]
[C01DA05, pentaerythritol tetranitrate, Venlafaxine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C01CX07, xamoterol, Venlafaxine may increase the tachycardic activities of Xamoterol.]
[S01GA03, xylometazoline, Venlafaxine may increase the tachycardic activities of Xylometazoline.]
[C08CA12, mepirodipine, The metabolism of Venlafaxine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, Venlafaxine may increase the tachycardic activities of Epinephrine.]
[N05CF02, zolpidem, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin glulisine.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Venlafaxine.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Venlafaxine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C02AC02, guanfacine, Venlafaxine may increase the tachycardic activities of Guanfacine.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Venlafaxine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Moricizine.]
[G02AB03, ergonovine, The risk or severity of serotonin syndrome can be increased when Ergometrine is combined with Venlafaxine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Venlafaxine.]
[N02CA02, ergotamine, The metabolism of Venlafaxine can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Venlafaxine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Venlafaxine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Estazolam.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Venlafaxine can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Venlafaxine may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Venlafaxine may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK02, ethambutol, Venlafaxine may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Venlafaxine.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C01CA15, gepefrine, The risk or severity of serotonin syndrome can be increased when Gepefrine is combined with Venlafaxine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Venlafaxine.]
[C01BD05, ibutilide, Venlafaxine may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N04AA05, profenamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ethotoin.]
[M01AC06, meloxicam, Venlafaxine may increase the antiplatelet activities of Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Venlafaxine.]
[C01CA01, etilefrine, Venlafaxine may increase the tachycardic activities of Etilefrine.]
[N01AX07, etomidate, Venlafaxine may increase the tachycardic activities of Etomidate.]
[L01CB01, etoposide, Venlafaxine may increase the excretion rate of Etoposide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AE03, sertindole, The risk or severity of serotonin syndrome can be increased when Sertindole is combined with Venlafaxine.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Venlafaxine.]
[R06AX12, terfenadine, The metabolism of Venlafaxine can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Venlafaxine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Venlafaxine.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Venlafaxine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Venlafaxine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C10AA03, pravastatin, Venlafaxine may increase the excretion rate of Pravastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[M01CB01, gold sodium thiomalate, Venlafaxine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Dextran is combined with Venlafaxine.]
[V03AF02, dexrazoxane, Venlafaxine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A16AA01, levocarnitine, Venlafaxine may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[C08CA02, felodipine, The metabolism of Venlafaxine can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Fenfluramine.]
[M01AE04, fenoprofen, Venlafaxine may increase the antiplatelet activities of Fenoprofen.]
[R03CC04, fenoterol, Venlafaxine may increase the tachycardic activities of Fenoterol.]
[N02AB03, fentanyl, The risk or severity of serotonin syndrome can be increased when Fentanyl is combined with Venlafaxine.]
[R03CC02, albuterol, Venlafaxine may increase the tachycardic activities of Salbutamol.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Venlafaxine.]
[L01BB06, clofarabine, Venlafaxine may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA40, cladribine, Venlafaxine may increase the excretion rate of Cladribine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Venlafaxine.]
[G04BD02, flavoxate, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Venlafaxine.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Venlafaxine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Venlafaxine may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Venlafaxine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Venlafaxine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of serotonin syndrome can be increased when Melitracen is combined with Venlafaxine.]
[V03AZ01, ethanol, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, Venlafaxine may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[L01BC02, fluorouracil, Venlafaxine may increase the excretion rate of Fluorouracil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AB03, fluoxetine, The serum concentration of Venlafaxine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of serotonin syndrome can be increased when Flupentixol is combined with Venlafaxine.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Fluphenazine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Flurazepam.]
[S01BC04, flurbiprofen, Venlafaxine may increase the antiplatelet activities of Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of serotonin syndrome can be increased when Fluspirilene is combined with Venlafaxine.]
[L02BB01, flutamide, Venlafaxine may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Venlafaxine may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[S02AA17, fosfomycin, Venlafaxine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L01BC03, tegafur, Venlafaxine may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, Venlafaxine may increase the tachycardic activities of Adrafinil.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of serotonin syndrome can be increased when Furazolidone is combined with Venlafaxine.]
[J05AE10, darunavir, The metabolism of Venlafaxine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Venlafaxine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Venlafaxine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Gallamine.]
[S01AD09, ganciclovir, Venlafaxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of serotonin syndrome can be increased when Bifemelane is combined with Venlafaxine.]
[C10AB04, gemfibrozil, Venlafaxine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Venlafaxine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Venlafaxine may increase the excretion rate of Dasatinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BC06, cabergoline, The risk or severity of serotonin syndrome can be increased when Cabergoline is combined with Venlafaxine.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Liraglutide.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of serotonin syndrome can be increased when Alfentanil is combined with Venlafaxine.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glipizide.]
[N05CM18, dexmedetomidine, Venlafaxine may increase the tachycardic activities of Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Glutethimide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Venlafaxine.]
[L01EX02, sorafenib, Venlafaxine may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Venlafaxine.]
[M01CB04, aurothioglucose, Venlafaxine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Venlafaxine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Venlafaxine.]
[C09AA09, fosinopril, Venlafaxine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EX01, guanethidine, Venlafaxine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Venlafaxine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Venlafaxine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Venlafaxine.]
[N06BX13, idebenone, Venlafaxine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin aspart.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Iprazochrome.]
[L01CE02, irinotecan, Venlafaxine may increase the excretion rate of Irinotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Allobarbital.]
[M04AA01, allopurinol, Venlafaxine may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Venlafaxine.]
[G03DC01, allylestrenol, Venlafaxine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Venlafaxine may increase the antiplatelet activities of Mesalazine.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Hexobarbital.]
[R03CC05, hexoprenaline, Venlafaxine may increase the tachycardic activities of Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Venlafaxine.]
[C08CA10, nilvadipine, The metabolism of Venlafaxine can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Venlafaxine.]
[C09AA04, perindopril, Venlafaxine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Venlafaxine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Venlafaxine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[G04BD06, propiverine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Venlafaxine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Prothipendyl.]
[B05AA07, hetastarch, Venlafaxine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[C02AC06, rilmenidine, Venlafaxine may increase the tachycardic activities of Rilmenidine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[B05XA08, sodium acetate, Venlafaxine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Venlafaxine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Venlafaxine.]
[L01AA06, ifosfamide, Venlafaxine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, The risk or severity of serotonin syndrome can be increased when Sufentanil is combined with Venlafaxine.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Venlafaxine.]
[R01AD07, tixocortol, Venlafaxine may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, Venlafaxine may increase the tachycardic activities of Tizanidine.]
[L01CE01, topotecan, Venlafaxine may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Venlafaxine may increase the antiplatelet activities of Indomethacin.]
[A11HA07, inositol, Venlafaxine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Milnacipran is combined with Venlafaxine.]
[A03AA30, piperidolate, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[S01XA28, varenicline, Venlafaxine may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Articaine.]
[A10BH01, sitagliptin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sitagliptin.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alprazolam.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ramelteon.]
[R06AE01, buclizine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Venlafaxine can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Venlafaxine.]
[C07AA01, alprenolol, The metabolism of Alprenolol can be decreased when combined with Venlafaxine.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Venlafaxine.]
[N06AA13, iprindole, The risk or severity of serotonin syndrome can be increased when Iprindole is combined with Venlafaxine.]
[N06AF05, iproniazid, The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Venlafaxine.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of serotonin syndrome can be increased when Isocarboxazid is combined with Venlafaxine.]
[R03CC06, isoetharine, Venlafaxine may increase the tachycardic activities of Isoetharine.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Isoflurane.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Entacapone.]
[J04AC01, isoniazid, The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Venlafaxine.]
[J05AX05, inosine pranobex, Venlafaxine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Venlafaxine may increase the tachycardic activities of Isoprenaline.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Exenatide.]
[D10BA01, isotretinoin, Venlafaxine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, Venlafaxine may increase the tachycardic activities of Isoxsuprine.]
[P02CF01, ivermectin, Venlafaxine may increase the excretion rate of Ivermectin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Venlafaxine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Venlafaxine.]
[S01AA24, kanamycin, Venlafaxine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Venlafaxine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Venlafaxine.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Venlafaxine.]
[J02AB02, ketoconazole, The serum concentration of Venlafaxine can be increased when it is combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Venlafaxine.]
[M02AA10, ketoprofen, Venlafaxine may increase the antiplatelet activities of Ketoprofen.]
[L04AA24, abatacept, The metabolism of Venlafaxine can be increased when combined with Abatacept.]
[C01CA22, arbutamine, Venlafaxine may increase the tachycardic activities of Arbutamine.]
[N04BC09, rotigotine, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Venlafaxine.]
[A16AX01, thioctic acid, The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Venlafaxine.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Venlafaxine.]
[N04BB01, amantadine, The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Venlafaxine.]
[A06AX03, lubiprostone, Venlafaxine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lacosamide.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BA01, levodopa, The risk or severity of serotonin syndrome can be increased when Levodopa is combined with Venlafaxine.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Venlafaxine.]
[S01AA21, amikacin, Venlafaxine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The risk or severity of serotonin syndrome can be increased when Lisuride is combined with Venlafaxine.]
[N06AA07, lofepramine, The risk or severity of serotonin syndrome can be increased when Lofepramine is combined with Venlafaxine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Venlafaxine.]
[C10AA02, lovastatin, The metabolism of Venlafaxine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of serotonin syndrome can be increased when Loxapine is combined with Venlafaxine.]
[L01EG01, temsirolimus, The metabolism of Venlafaxine can be decreased when combined with Temsirolimus.]
[B05XA11, magnesium chloride, Venlafaxine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Venlafaxine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Venlafaxine can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, Venlafaxine may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EA03, nilotinib, The metabolism of Venlafaxine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The risk or severity of serotonin syndrome can be increased when Maprotiline is combined with Venlafaxine.]
[A08AA05, mazindol, The risk or severity of serotonin syndrome can be increased when Mazindol is combined with Venlafaxine.]
[C02BB01, mecamylamine, Venlafaxine may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Venlafaxine.]
[M02AA18, meclofenamic acid, Venlafaxine may increase the antiplatelet activities of Meclofenamic acid.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Medazepam.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Venlafaxine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Venlafaxine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Venlafaxine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Melatonin.]
[N06DX01, memantine, Venlafaxine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, The risk or severity of serotonin syndrome can be increased when Meperidine is combined with Venlafaxine.]
[C01CA11, mephentermine, The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Venlafaxine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Venlafaxine.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Meprobamate.]
[N02AX05, meptazinol, The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Venlafaxine.]
[G04BX16, tiopronin, Venlafaxine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Venlafaxine.]
[N05AX13, paliperidone, The risk or severity of serotonin syndrome can be increased when Paliperidone is combined with Venlafaxine.]
[C01CA09, metaraminol, Venlafaxine may increase the tachycardic activities of Metaraminol.]
[A10BA02, metformin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Metformin.]
[A04AA04, dolasetron, The risk or severity of serotonin syndrome can be increased when Dolasetron is combined with Venlafaxine.]
[H01CB03, lanreotide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Lanreotide.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Venlafaxine.]
[N06BA03, methamphetamine, The risk or severity of serotonin syndrome can be increased when Metamfetamine is combined with Venlafaxine.]
[A03AB07, methantheline, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methaqualone.]
[J05AF05, lamivudine, Venlafaxine may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Metharbital.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Venlafaxine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Venlafaxine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methocarbamol.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methohexital.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ziconotide.]
[L04AX03, methotrexate, Venlafaxine may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA02, methotrimeprazine, The risk or severity of serotonin syndrome can be increased when Methotrimeprazine is combined with Venlafaxine.]
[C01CA10, methoxamine, Venlafaxine may increase the tachycardic activities of Methoxamine.]
[D05BA02, methoxsalen, Venlafaxine may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Venlafaxine.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Venlafaxine may increase the tachycardic activities of Methyldopa.]
[V04CG05, methylene blue, Venlafaxine may increase the serotonergic activities of Methylene blue.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Venlafaxine.]
[G03EK01, methyltestosterone, Venlafaxine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Venlafaxine.]
[A03FA01, metoclopramide, The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The serum concentration of Metoprolol can be increased when it is combined with Venlafaxine.]
[V04CD01, metyrapone, Venlafaxine may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Venlafaxine.]
[N06AX03, mianserin, The risk or severity of serotonin syndrome can be increased when Mianserin is combined with Venlafaxine.]
[S02AA13, miconazole, The metabolism of Venlafaxine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Venlafaxine.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Venlafaxine.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Midazolam.]
[C01CA17, midodrine, Venlafaxine may increase the tachycardic activities of Midodrine.]
[G03XB01, mifepristone, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Venlafaxine.]
[J05AH01, zanamivir, Venlafaxine may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[L01XX23, mitotane, The metabolism of Venlafaxine can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, Venlafaxine may increase the excretion rate of Mitoxantrone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA12, lisdexamfetamine, The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Venlafaxine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Molindone.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Venlafaxine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Venlafaxine.]
[N02AA01, morphine, The risk or severity of serotonin syndrome can be increased when Morphine is combined with Venlafaxine.]
[A04AA05, palonosetron, The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Venlafaxine.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Venlafaxine can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Venlafaxine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Venlafaxine.]
[L04AA06, mycophenolic acid, Venlafaxine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Amobarbital.]
[G03XC01, raloxifene, Venlafaxine may increase the excretion rate of Raloxifene which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Venlafaxine.]
[N03AB05, fosphenytoin, The metabolism of Venlafaxine can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Venlafaxine.]
[J01CA04, amoxicillin, Venlafaxine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, Venlafaxine may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Venlafaxine.]
[V03AB15, naloxone, The metabolism of Venlafaxine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Venlafaxine.]
[L04AC03, anakinra, The metabolism of Venlafaxine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Venlafaxine may increase the tachycardic activities of Naphazoline.]
[N06BA01, amphetamine, The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Venlafaxine.]
[M02AA12, naproxen, Venlafaxine may increase the antiplatelet activities of Naproxen.]
[A10BG01, troglitazone, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Duloxetine is combined with Venlafaxine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Tolcapone.]
[S03AA01, neomycin, Venlafaxine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of serotonin syndrome can be increased when Remifentanil is combined with Venlafaxine.]
[A10BX02, repaglinide, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Repaglinide.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Venlafaxine.]
[N05AX14, iloperidone, The risk or severity of serotonin syndrome can be increased when Iloperidone is combined with Venlafaxine.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[S01AA19, ampicillin, Venlafaxine may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Venlafaxine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Venlafaxine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Venlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C01CE01, inamrinone, Venlafaxine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Venlafaxine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Venlafaxine.]
[C08CA04, nicardipine, The metabolism of Venlafaxine can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Venlafaxine.]
[N07BA01, nicotine, The risk or severity of Tachycardia can be increased when Nicotine is combined with Venlafaxine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Venlafaxine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C08CA07, nisoldipine, Venlafaxine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nitrazepam.]
[R07AX01, nitric oxide, Venlafaxine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Venlafaxine may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zaleplon.]
[N04BC05, pramipexole, Venlafaxine may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Venlafaxine may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Nomifensine.]
[C01CA03, norepinephrine, Venlafaxine may increase the tachycardic activities of Norepinephrine.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Venlafaxine.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Venlafaxine.]
[G02CA02, nylidrin, Venlafaxine may increase the tachycardic activities of Nylidrin.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Venlafaxine.]
[H01CB02, octreotide, The risk or severity of hypoglycemia can be increased when Octreotide is combined with Venlafaxine.]
[L04AC04, rilonacept, The metabolism of Venlafaxine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Venlafaxine can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of serotonin syndrome can be increased when Opipramol is combined with Venlafaxine.]
[N02AA02, opium, The risk or severity of serotonin syndrome can be increased when Opium is combined with Venlafaxine.]
[R03CB03, metaproterenol, Venlafaxine may increase the tachycardic activities of Orciprenaline.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Venlafaxine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Venlafaxine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Venlafaxine.]
[J01CF04, oxacillin, Venlafaxine may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[P02BA02, oxamniquine, The metabolism of Venlafaxine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxazepam.]
[C07AA02, oxprenolol, The metabolism of Oxprenolol can be decreased when combined with Venlafaxine.]
[N02AA05, oxycodone, The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Venlafaxine.]
[C01DX03, oxyfedrine, Venlafaxine may increase the tachycardic activities of Oxyfedrine.]
[S01GA04, oxymetazoline, Venlafaxine may increase the tachycardic activities of Oxymetazoline.]
[N02AA11, oxymorphone, The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Venlafaxine.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[A03AB03, oxyphenonium, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The risk or severity of serotonin syndrome can be increased when Asenapine is combined with Venlafaxine.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Venlafaxine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[M03AC01, pancuronium, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[J04AB30, capreomycin, Venlafaxine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[N05CC05, paraldehyde, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Venlafaxine.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Venlafaxine.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Venlafaxine.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Venlafaxine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N02AD01, pentazocine, The risk or severity of serotonin syndrome can be increased when Pentazocine is combined with Venlafaxine.]
[N05CA01, pentobarbital, The metabolism of Venlafaxine can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Venlafaxine may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Venlafaxine.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of serotonin syndrome can be increased when Pergolide is combined with Venlafaxine.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Venlafaxine.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Venlafaxine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Venlafaxine.]
[N02AD02, phenazocine, The risk or severity of serotonin syndrome can be increased when Phenazocine is combined with Venlafaxine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N06AF03, phenelzine, The risk or severity of serotonin syndrome can be increased when Phenelzine is combined with Venlafaxine.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Venlafaxine.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Venlafaxine.]
[N03AA02, phenobarbital, The metabolism of Venlafaxine can be increased when combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of serotonin syndrome can be increased when Phenoperidine is combined with Venlafaxine.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Phenprocoumon is combined with Venlafaxine.]
[A08AA01, phentermine, The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Venlafaxine.]
[V03AB36, phentolamine, Venlafaxine may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Venlafaxine may increase the antiplatelet activities of Phenylbutazone.]
[S01GA05, phenylephrine, Venlafaxine may increase the tachycardic activities of Phenylephrine.]
[R01BA01, phenylpropanolamine, Venlafaxine may increase the tachycardic activities of Phenylpropanolamine.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Venlafaxine.]
[L04AB06, golimumab, The metabolism of Venlafaxine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Venlafaxine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Venlafaxine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Venlafaxine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Venlafaxine.]
[C07AA03, pindolol, The risk or severity of serotonin syndrome can be increased when Pindolol is combined with Venlafaxine.]
[J01CA12, piperacillin, Venlafaxine may decrease the excretion rate of Piperacillin which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Venlafaxine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Venlafaxine.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Venlafaxine.]
[N06BX03, piracetam, Venlafaxine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[A02BX03, pirenzepine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Venlafaxine.]
[S01BC06, piroxicam, Venlafaxine may increase the antiplatelet activities of Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[N02CX01, pizotyline, The risk or severity of serotonin syndrome can be increased when Pizotifen is combined with Venlafaxine.]
[J05AG02, delavirdine, The metabolism of Venlafaxine can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Proxibarbal.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Venlafaxine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Venlafaxine.]
[A10BG02, rosiglitazone, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Rosiglitazone.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Venlafaxine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Venlafaxine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Saxagliptin.]
[B05XA01, potassium chloride, Venlafaxine may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin lispro.]
[C10AA08, pitavastatin, Venlafaxine may increase the excretion rate of Pitavastatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Venlafaxine.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Prazepam.]
[C02CA01, prazosin, Venlafaxine may increase the excretion rate of Prazosin which could result in a lower serum level and potentially a reduction in efficacy.]
[H02AB07, prednisone, Venlafaxine may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Venlafaxine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Venlafaxine can be increased when combined with Primidone.]
[M04AB01, probenecid, Venlafaxine may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Venlafaxine.]
[S01HA05, procaine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Venlafaxine.]
[L01XB01, procarbazine, The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Venlafaxine.]
[C10AB05, fenofibrate, Venlafaxine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Venlafaxine.]
[N04AA04, procyclidine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Venlafaxine.]
[N05AA03, promazine, The risk or severity of serotonin syndrome can be increased when Promazine is combined with Venlafaxine.]
[R06AD02, promethazine, The risk or severity of serotonin syndrome can be increased when Promethazine is combined with Venlafaxine.]
[C01BC03, propafenone, The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Propanidid.]
[A03AB05, propantheline, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Periciazine.]
[N05CM06, propiomazine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of serotonin syndrome can be increased when Dextropropoxyphene is combined with Venlafaxine.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Venlafaxine.]
[N02CC04, rizatriptan, The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Venlafaxine.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Venlafaxine.]
[N06AA11, protriptyline, The risk or severity of serotonin syndrome can be increased when Protriptyline is combined with Venlafaxine.]
[R01BA02, pseudoephedrine, The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Venlafaxine.]
[N05AX12, aripiprazole, The risk or severity of serotonin syndrome can be increased when Aripiprazole is combined with Venlafaxine.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Venlafaxine is combined with Dalfampridine.]
[A03AB15, diphemanil, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Talbutal.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Pyrantel.]
[J04AK01, pyrazinamide, Venlafaxine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Mepyramine.]
[C01BA01, quinidine, The metabolism of Venlafaxine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Venlafaxine.]
[A02BA02, ranitidine, The metabolism of Venlafaxine can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Reserpine.]
[J05AP01, ribavirin, Venlafaxine may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Venlafaxine can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, Venlafaxine may increase the tachycardic activities of Rimiterol.]
[G02CA01, ritodrine, Venlafaxine may increase the tachycardic activities of Ritodrine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Oxitriptan.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[A07EC01, sulfasalazine, Venlafaxine may increase the antiplatelet activities of Sulfasalazine.]
[S01BC08, salicylic acid, Venlafaxine may increase the antiplatelet activities of Salicylic acid.]
[S01FA02, scopolamine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Secobarbital.]
[N04BD01, selegiline, The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Venlafaxine.]
[J01GB08, sisomicin, Venlafaxine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Venlafaxine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Venlafaxine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Venlafaxine.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG01, valproic acid, The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Venlafaxine.]
[C01DA14, isosorbide mononitrate, Venlafaxine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[H02CA04, levoketoconazole, The metabolism of Venlafaxine can be decreased when combined with Levoketoconazole.]
[D10AX03, azelaic acid, Venlafaxine may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Venlafaxine may increase the antiplatelet activities of Tiaprofenic acid.]
[R03BB01, ipratropium bromide, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N06AF04, tranylcypromine, Selective serotonin reuptake inhibitors (SSRIs) -  monoamine oxidase (MAO) inhibitors]
[N06AF01, isocarboxazid, Selective serotonin reuptake inhibitors (SSRIs) -  monoamine oxidase (MAO) inhibitors]
[N06AF03, phenelzine, Selective serotonin reuptake inhibitors (SSRIs) -  monoamine oxidase (MAO) inhibitors]
[L01XB01, procarbazine, Selective serotonin reuptake inhibitors (SSRIs) -  monoamine oxidase (MAO) inhibitors]
[N04BD01, selegiline, Selective serotonin reuptake inhibitors (SSRIs) -  monoamine oxidase (MAO) inhibitors]
